Vitamin E and Cancer: an Update on the Emerging Role of γ and δ Tocotrienols

Overview

Journal Eur J Nutr

Specialty Nutritional Sciences

Date 2019 Apr 25

PMID 31016386

Citations 24

Authors

Constantina Constantinou

Christiana Charalambous

Dimitrios Kanakis

Affiliations

Soon will be listed here.

Abstract

Despite significant advances in the diagnosis and treatment of cancer, the latter still remains a fatal disease due to the lack of prevention, early diagnosis, and effective drugs. Radiotherapy, chemotherapy, and surgery are not only expensive but produce a number of side effects that are detrimental to the patients' quality of life. Therefore, there is a great need to discover anti-cancer therapies that are specific to cancer cells and affordable, safe, and well tolerated by the patients. Vitamin E is a potential candidate due to its safety. Accumulating evidence on the anti-cancer potency of vitamin E has shifted the focus from tocopherols (TOCs) to tocotrienols (TTs). γ-TT and δ-TT have the highest anti-cancer activities and target common molecular pathways involved in the inhibition of the cell cycle, the induction of apoptosis and autophagy, and the inhibition of invasion, metastasis, and angiogenesis. Future directions should focus on further investigating how γ-TT and δ-TT (solely or in combination) induce anti-cancer molecular pathways when used in the presence of conventional chemotherapeutic drugs. These studies should be carried out in vitro, and promising results and combinations should then be assessed in in vivo experiments and finally in clinical trials. Finally, future research should focus on further evaluating the roles of γ-TT and δ-TT in the chemoprevention of cancer.

Citing Articles

Connection between nutrition and oncology in dogs and cats: perspectives, evidence, and implications-a comprehensive review.

Amaral A, Finardi G, Marchi P, de Oliveira N, Principe L, Teixeira N Front Vet Sci. 2025; 11:1490290.

PMID: 40046187 PMC: 11881598. DOI: 10.3389/fvets.2024.1490290.

Bee Pollen Phytochemicals and Nutrients as Unequaled Pool of Epigenetic Regulators: Implications for Age-Related Diseases.

Kacemi R, Campos M Foods. 2025; 14(3).

PMID: 39941940 PMC: 11816923. DOI: 10.3390/foods14030347.

Molecular Insights in the Anticancer Activity of Natural Tocotrienols: Targeting Mitochondrial Metabolism and Cellular Redox Homeostasis.

Chiaramonte R, Sauro G, Giannandrea D, Limonta P, Casati L Antioxidants (Basel). 2025; 14(1).

PMID: 39857449 PMC: 11760857. DOI: 10.3390/antiox14010115.

The use of vitamin E in ocular health: Bridging omics approaches with Tocopherol and Tocotrienol in the management of glaucoma.

Latib F, Zafendi M, Lazaldin M Food Chem (Oxf). 2024; 9:100224.

PMID: 39415777 PMC: 11481750. DOI: 10.1016/j.fochms.2024.100224.

Role of Vitamins in Therapeutic and Targeting Approaches for Prostate Cancer: An Overview.

Panda P, Saraf S, Verma A, Jain A, Bidla P, Raikwar S Curr Drug Targets. 2024; 25(14):934-952.

PMID: 39257155 DOI: 10.2174/0113894501314558240822082557.

References

Constantinou C, Papas K, Constantinou A . Caspase-independent pathways of programmed cell death: the unraveling of new targets of cancer therapy?. Curr Cancer Drug Targets. 2009; 9(6):717-28. DOI: 10.2174/156800909789271512. View

Parajuli P, Tiwari R, Sylvester P . Anti-proliferative effects of γ-tocotrienol are associated with suppression of c-Myc expression in mammary tumour cells. Cell Prolif. 2015; 48(4):421-35. PMC: 6496305. DOI: 10.1111/cpr.12196. View

Bachawal S, Wali V, Sylvester P . Combined gamma-tocotrienol and erlotinib/gefitinib treatment suppresses Stat and Akt signaling in murine mammary tumor cells. Anticancer Res. 2010; 30(2):429-37. View

Shin-Kang S, Ramsauer V, Lightner J, Chakraborty K, Stone W, Campbell S . Tocotrienols inhibit AKT and ERK activation and suppress pancreatic cancer cell proliferation by suppressing the ErbB2 pathway. Free Radic Biol Med. 2011; 51(6):1164-74. DOI: 10.1016/j.freeradbiomed.2011.06.008. View

Luk S, Yap W, Chiu Y, Lee D, Ma S, Lee T . Gamma-tocotrienol as an effective agent in targeting prostate cancer stem cell-like population. Int J Cancer. 2010; 128(9):2182-91. DOI: 10.1002/ijc.25546. View

Kannappan R, Ravindran J, Prasad S, Sung B, Yadav V, Reuter S . Gamma-tocotrienol promotes TRAIL-induced apoptosis through reactive oxygen species/extracellular signal-regulated kinase/p53-mediated upregulation of death receptors. Mol Cancer Ther. 2010; 9(8):2196-207. DOI: 10.1158/1535-7163.MCT-10-0277. View

Sperandio S, de Belle I, Bredesen D . An alternative, nonapoptotic form of programmed cell death. Proc Natl Acad Sci U S A. 2000; 97(26):14376-81. PMC: 18926. DOI: 10.1073/pnas.97.26.14376. View

Sailo B, Banik K, Padmavathi G, Javadi M, Bordoloi D, Kunnumakkara A . Tocotrienols: The promising analogues of vitamin E for cancer therapeutics. Pharmacol Res. 2018; 130:259-272. DOI: 10.1016/j.phrs.2018.02.017. View

Hsieh T, Wu J . Suppression of cell proliferation and gene expression by combinatorial synergy of EGCG, resveratrol and gamma-tocotrienol in estrogen receptor-positive MCF-7 breast cancer cells. Int J Oncol. 2008; 33(4):851-9. View

10.

Chang P, Yap W, Lee D, Ling M, Wong Y, Yap Y . Evidence of gamma-tocotrienol as an apoptosis-inducing, invasion-suppressing, and chemotherapy drug-sensitizing agent in human melanoma cells. Nutr Cancer. 2009; 61(3):357-66. DOI: 10.1080/01635580802567166. View

11.

Degterev A, Boyce M, Yuan J . A decade of caspases. Oncogene. 2003; 22(53):8543-67. DOI: 10.1038/sj.onc.1207107. View

12.

Comitato R, Guantario B, Leoni G, Nesaretnam K, Ronci M, Canali R . Tocotrienols induce endoplasmic reticulum stress and apoptosis in cervical cancer cells. Genes Nutr. 2016; 11:32. PMC: 5180413. DOI: 10.1186/s12263-016-0543-1. View

13.

Kanchi M, Shanmugam M, Rane G, Sethi G, Kumar A . Tocotrienols: the unsaturated sidekick shifting new paradigms in vitamin E therapeutics. Drug Discov Today. 2017; 22(12):1765-1781. DOI: 10.1016/j.drudis.2017.08.001. View

14.

Kunnumakkara A, Sung B, Ravindran J, Diagaradjane P, Deorukhkar A, Dey S . {Gamma}-tocotrienol inhibits pancreatic tumors and sensitizes them to gemcitabine treatment by modulating the inflammatory microenvironment. Cancer Res. 2010; 70(21):8695-705. PMC: 2970705. DOI: 10.1158/0008-5472.CAN-10-2318. View

15.

Wang H, Luo J, Tian W, Yan W, Ge S, Zhang Y . γ-Tocotrienol inhibits oxidative phosphorylation and triggers apoptosis by inhibiting mitochondrial complex I subunit NDUFB8 and complex II subunit SDHB. Toxicology. 2019; 417:42-53. DOI: 10.1016/j.tox.2019.01.018. View

16.

Shibata A, Nakagawa K, Tsuduki T, Miyazawa T . δ-Tocotrienol treatment is more effective against hypoxic tumor cells than normoxic cells: potential implications for cancer therapy. J Nutr Biochem. 2015; 26(8):832-40. DOI: 10.1016/j.jnutbio.2015.02.011. View

17.

Murtaugh M, Ma K, Benson J, Curtin K, Caan B, Slattery M . Antioxidants, carotenoids, and risk of rectal cancer. Am J Epidemiol. 2003; 159(1):32-41. DOI: 10.1093/aje/kwh013. View

18.

Xiong A, Yu W, Liu Y, Sanders B, Kline K . Elimination of ALDH+ breast tumor initiating cells by docosahexanoic acid and/or gamma tocotrienol through SHP-1 inhibition of Stat3 signaling. Mol Carcinog. 2015; 55(5):420-30. DOI: 10.1002/mc.22291. View

19.

Tiwari R, Parajuli P, Sylvester P . γ-Tocotrienol-induced autophagy in malignant mammary cancer cells. Exp Biol Med (Maywood). 2013; 239(1):33-44. DOI: 10.1177/1535370213511022. View

20.

Cardenas E, Ghosh R . Vitamin E: a dark horse at the crossroad of cancer management. Biochem Pharmacol. 2013; 86(7):845-52. PMC: 4100069. DOI: 10.1016/j.bcp.2013.07.018. View